Clark's Rule

Clark's Rule is a weight-based pediatric dosing formula that estimates the appropriate medication dose for children aged 2-17 years by proportionally adjusting the adult dose based on the child's weight compared to an average adult weight of 150 pounds (68 kg). The formula is: Child dose = (Child's weight in pounds ÷ 150) × Adult dose. For example, if the adult dose of a medication is 500 mg and the child weighs 75 pounds, the calculation would be: (75 ÷ 150) × 500 mg = 250 mg. This means the child receives exactly half the adult dose because they weigh half as much as the reference adult weight. Clark's Rule assumes a linear relationship between body weight and drug clearance, which is reasonably accurate for many medications in children over 2 years old who have mature organ function. However, it's important to note that this is a simplified estimation method—actual pediatric dosing often requires consideration of factors beyond weight, including age-specific metabolism, organ maturity, body surface area, and drug-specific pharmacokinetics. For a 100-pound child receiving a medication with an adult dose of 400 mg, Clark's Rule yields: (100 ÷ 150) × 400 mg = 267 mg. Modern pediatric pharmacotherapy increasingly relies on body surface area calculations or mg/kg dosing for greater precision, but Clark's Rule remains useful as a quick estimation tool and is still referenced in some clinical settings, particularly for medications where precise dosing charts are unavailable.

Clark's Rule is generally considered appropriate for children aged 2-17 years who have reached sufficient physiological maturity for weight-proportional dosing. Children under 2 years should use Fried's Rule instead (based on age in months), as infants and toddlers have immature hepatic and renal function that doesn't correlate predictably with weight. Clark's Rule works best for medications with wide therapeutic windows—drugs where small dosing variations don't cause toxicity or therapeutic failure. Examples include: acetaminophen (adult dose 650-1000 mg; for a 60-pound child: (60÷150)×650 = 260 mg every 4-6 hours), ibuprofen (adult dose 400-600 mg; for an 80-pound child: (80÷150)×400 = 213 mg), diphenhydramine (adult dose 25-50 mg; for a 50-pound child: (50÷150)×50 = 17 mg), and guaifenesin (adult dose 400 mg; for a 90-pound child: (90÷150)×400 = 240 mg). Clark's Rule should NOT be used for: (1) Narrow therapeutic index drugs like digoxin, warfarin, phenytoin, or chemotherapy agents, which require precise mg/kg or body surface area dosing to avoid toxicity; (2) Infants under 2 years, whose immature metabolism makes weight-based estimation unreliable; (3) Obese children, as excess adipose tissue doesn't proportionally increase drug clearance—a 200-pound child shouldn't receive 133% of the adult dose; (4) Medications where manufacturer-specific pediatric dosing guidelines exist, which should always take precedence over estimation formulas; (5) IV medications, particularly in critical care settings, where precise mg/kg dosing is mandatory. For antibiotics, most clinicians use specific mg/kg dosing: amoxicillin 20-40 mg/kg/day rather than Clark's Rule estimation. The rule is best reserved for over-the-counter medications, select oral medications without specific pediatric guidelines, and situations where quick estimation is needed pending consultation with a pharmacist or pediatrician.

The three primary pediatric dosing methods—Clark's Rule, body surface area (BSA), and mg/kg dosing—often yield different results, with mg/kg being most accurate for most medications. Consider a 60-pound (27.3 kg) child who is 48 inches (122 cm) tall receiving a medication with an adult dose of 500 mg. Clark's Rule: (60 ÷ 150) × 500 mg = 200 mg. Body Surface Area method: Child's BSA = √[(height in cm × weight in kg) ÷ 3600] = √[(122 × 27.3) ÷ 3600] = 0.92 m². Adult BSA averages 1.73 m², so the dose = (0.92 ÷ 1.73) × 500 mg = 266 mg. Mg/kg method: If the medication's pediatric dosing is 10 mg/kg, the dose = 10 × 27.3 = 273 mg. The mg/kg calculation yields the highest dose because it's based on the specific drug's pharmacokinetics in children. BSA dosing yields a middle value and is preferred for chemotherapy agents and many antibiotics because body surface area correlates better with metabolic rate and renal clearance than weight alone. Clark's Rule gives the lowest dose, which can be underdosing for some medications. For example, a 120-pound (54.5 kg) adolescent: Clark's Rule gives (120÷150)×500 = 400 mg, while mg/kg at 10 mg/kg gives 545 mg—a 36% difference! This discrepancy occurs because Clark's Rule assumes linear scaling to 150 pounds, but larger children often require more than 80% of the adult dose to achieve therapeutic levels. Conversely, for obese pediatric patients, Clark's Rule may overestimate—a 180-pound child would receive 600 mg by Clark's Rule (120% of adult dose), but mg/kg dosing using ideal body weight might yield only 400 mg. Modern practice strongly favors mg/kg dosing when available because it accounts for drug-specific pharmacokinetics, provides dosing across the weight spectrum, and has extensive validation. Clark's Rule remains useful only when mg/kg guidelines are unavailable or for rapid estimation, with the understanding that it provides an approximation requiring clinical judgment.

Let's examine practical calculations for commonly used medications: Acetaminophen (Tylenol): Adult dose is 650 mg every 4-6 hours. For a 45-pound child: (45 ÷ 150) × 650 = 195 mg. Standard pediatric acetaminophen suspension contains 160 mg/5 mL, so this child needs 6.1 mL (approximately 1.25 teaspoons). Compare this to the package recommendation of 10-15 mg/kg: 45 pounds = 20.5 kg, so 10-15 mg/kg = 205-307 mg, making Clark's Rule estimate slightly conservative but reasonable. Ibuprofen (Advil/Motrin): Adult dose is 400 mg every 6-8 hours. For a 70-pound child: (70 ÷ 150) × 400 = 187 mg. Pediatric suspension is 100 mg/5 mL, requiring 9.4 mL. This aligns well with standard pediatric dosing of 5-10 mg/kg (70 lb = 31.8 kg × 5-10 = 159-318 mg range). Diphenhydramine (Benadryl): Adult dose is 50 mg every 4-6 hours. For a 55-pound child: (55 ÷ 150) × 50 = 18.3 mg. Children's Benadryl is 12.5 mg/5 mL, so administer 7.3 mL. Standard dosing is 1 mg/kg, and 55 lb = 25 kg, so 25 mg by mg/kg method—Clark's Rule underestimates by 27% in this case. Amoxicillin: Standard adult dose is 500 mg three times daily. For an 85-pound child: (85 ÷ 150) × 500 = 283 mg per dose. However, pediatric amoxicillin is typically dosed at 20-40 mg/kg/day divided into 3 doses: 85 lb = 38.6 kg, so 20-40 mg/kg/day = 772-1544 mg/day ÷ 3 = 257-515 mg per dose. Clark's Rule falls at the lower end, potentially underdosing for serious infections. Guaifenesin (Mucinex): Adult dose is 400 mg every 4 hours. For a 65-pound child: (65 ÷ 150) × 400 = 173 mg. Pediatric formulation is 100 mg/5 mL, requiring 8.7 mL. These examples illustrate that Clark's Rule provides reasonable estimates for OTC medications with wide therapeutic windows, but should be verified against mg/kg dosing when possible and adjusted based on clinical response.

Several critical safety principles must guide Clark's Rule usage to prevent dosing errors: (1) Never round up aggressively—if calculation yields 247 mg and available tablets are 250 mg, using 250 mg is acceptable, but rounding 247 mg to 300 mg introduces 21% overdosing. Always round to the nearest practical dose, erring slightly lower if uncertain. (2) Weight verification—use current, accurate weights measured in clinical settings. Parent-reported weights can be inaccurate by 5-15%, particularly for younger children. A 10-pound error in a 50-pound child changes the dose by 20%. (3) Unit consistency—Clark's Rule uses pounds, not kilograms. A 30-kg child weighs 66 pounds, not 30 pounds. Using 30 in the formula would underdose by 55%: (30÷150)×500 = 100 mg instead of the correct (66÷150)×500 = 220 mg. Convert kg to pounds by multiplying by 2.2. (4) Maximum dose limits—even if Clark's Rule calculation suggests a dose, never exceed the adult maximum. If a 160-pound adolescent's calculated dose exceeds the adult maximum daily dose, cap it at the adult limit. For acetaminophen with adult maximum of 4000 mg/day, a large teenager shouldn't receive more than 4000 mg/day regardless of weight. (5) Drug-specific warnings—some medications have absolute pediatric contraindications: aspirin is contraindicated under age 12 due to Reye's syndrome risk; codeine is contraindicated under age 12 due to respiratory depression risk. Clark's Rule doesn't override these restrictions. (6) Obesity adjustments—for obese children, consider using ideal body weight instead of actual weight. A 180-pound child may have an ideal weight of 120 pounds based on height/age; using actual weight might overdose lipophilic drugs. (7) Liquid medication concentration errors—after calculating the dose in mg, carefully convert to mL using the specific concentration. Confusion between children's (160 mg/5 mL) and infant's (80 mg/0.8 mL) acetaminophen concentrations has caused fatal overdoses. (8) Multiple formulation checking—verify you're using the correct adult dose for the formulation. Extended-release adult tablets may have different dosing than immediate-release, and using the wrong reference dose propagates through Clark's Rule calculation. Always document the calculation, consult drug references when available, and involve pharmacists for high-risk medications or complex situations.

Pediatric pharmacotherapy has advanced significantly beyond simple proportional rules like Clark's, with modern practice emphasizing evidence-based, individualized dosing. Physiologically-based approaches recognize that children aren't just small adults—they have age-dependent differences in drug absorption (higher gastric pH in infants), distribution (higher body water percentage), metabolism (immature CYP450 enzymes under age 2, then hyperactive metabolism ages 2-12), and elimination (reduced renal function in infants, normalized by age 2). These factors mean a 40-pound 3-year-old may require different dosing than a 40-pound 8-year-old with developmental delays. Body surface area dosing has become standard for chemotherapy, where the therapeutic index is narrow and BSA correlates better with metabolic rate: carboplatin dosing uses the Calvert formula based on BSA and renal function, not weight alone. Therapeutic drug monitoring allows real-time dose optimization for drugs like vancomycin, where initial doses are calculated by mg/kg but then adjusted based on measured blood levels to maintain trough concentrations of 10-20 mcg/mL. Pharmacogenetic testing is emerging for medications metabolized by polymorphic enzymes: children with CYP2D6 ultra-rapid metabolizer status may require 50% dose reduction of codeine due to excessive morphine production, while poor metabolizers need alternative analgesics. Age and weight-banded dosing simplifies administration while maintaining safety—emergency medications like epinephrine use color-coded systems: red zone (3-5 kg, 0.05 mg), blue zone (6-7 kg, 0.1 mg), etc. Regulatory requirements now mandate pediatric clinical trials for many drugs, generating specific pediatric dosing based on actual pharmacokinetic/pharmacodynamic data rather than extrapolation from adults. For example, ondansetron for pediatric nausea is dosed 0.15 mg/kg (max 16 mg) based on pediatric trials, not Clark's Rule approximation. Clinical decision support systems integrated into electronic health records calculate doses automatically, flag excessive doses, and provide age-appropriate ranges, reducing calculation errors by 50-80%. Best practice guidelines recommend: (1) Use manufacturer's pediatric dosing when available; (2) For off-label medications, consult pediatric formularies like Pediatric & Neonatal Dosage Handbook; (3) Employ mg/kg dosing as first-line method; (4) Use BSA for chemotherapy and select antibiotics; (5) Reserve estimation rules like Clark's for rapid approximation only, not definitive dosing; (6) Involve pediatric pharmacists for complex regimens, renal/hepatic impairment, or medication interactions; (7) Re-calculate doses as children grow—a dose appropriate at age 5 may be inadequate by age 8 if the child has gained 15 pounds. The evolution toward precision pediatric dosing has dramatically improved efficacy and safety compared to the era when Clark's Rule was the primary method.